Insulin resistance and its correlation with body composition in patients with obese polycystic ovary syndrome
王静,沈山梅,孙海翔,朱大龙,毕艳,陈建平,陈晓甜,王淑安
DOI: https://doi.org/10.3760/cma.j.issn.1674-635X.2015.06.006
2015-01-01
Abstract:Objective To explore the incidence of insulin resistance (IR) in patients with obese polycystic ovary syndrome (PCOS) and its relationship with body composition including body fat (BF) and visceral fat area (VFA).Methods In the period from April 2013 to December 2014, in Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, 62 patients with obese PCOS who were in the weight loss program in the Department of Clinical Nutrition were selected, and 19 obesity subjects without PCOS, matching with the obsess PCOS group in age and body mass index (BMI), were selected as controls.In the cases and controls, we used Biospace Inbody720 body composition analyzer to determine their body composition, measured serum lipid profile, conducted 75 g oral glucose tolerance test and insulin release test, and calculated homeostasis model assessment of insulin resistance (HOMA-IR).Results Blood lipids, insulin level, and HOMA-IR were not significantly different between the obese PCOS and the control groups (all P ＞ 0.05).Both groups showed IR (defined as HOMA-IR≥2.69), and HOMA-IR in the obese PCOS group was higher than that in the control group, but with no significant difference (6.17 ± 3.15 vs.5.00 ±2.18, t =1.515, P =0.134).The mean alanine aminotransferase (ALT) level in the obese PCOS group was higher than normal, and the ALT values and the proportion of patients with ALT ＞ 40 U/L were higher than those in the control group, but with no significant difference (P =0.106 and P =0.134).Those with nonalcoholic fatty liver disease (NAFLD) accounted for 27/62 in the obese PCOS group, also higher than the 6/19 in the control group (x2 =0.863, P =0.353).BF in the obese PCOS group was lower than that in the control group [(36.28±6.16) kgvs.(39.56±6.13) kg, t=-2.032, P=0.046], so was VFA after adjusting for waist-to-hip ratio [(150.39 ± 22.86) cm2 vs.(161.74 ± 20.77) cm2, OR =0.963, P =0.040].Linear regression analysis showed that HOMA-IR was not correlated with BF, VFA or other body composition indexes in the obese PCOS patients (all P ＞ 0.05).Conclusions Obesity PCOS patients have significant IR, but HOMA-IR seems to be not correlated with BF, VFA, and other body composition indexes in this population.Studies with larger sample size and exploring relevant mechanisms are still needed.